Publications by authors named "Mike Scully"

Claim this Profile
I
Impact of changes to the delivery of opioid agonist treatment, introduced during the COVID-19 pandemic, on treatment access and dropout in Ireland: An interrupted time series analysis.
Louise Durand, Fiona Boland, Norma Harnedy, Íde Delargy, Mike Scully

J Subst Use Addict Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: A national Delphi study.
Louise Durand, Eamon Keenan, Fiona Boland, Norma Harnedy, Íde Delargy, Mike Scully

Int J Drug Policy· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An audit of the cervical screening programme in the National Drug Treatment Centre (NDTC).
Maeve Haran, John R Kelly, Liam Kennedy, Kieran Hennigan, Huma Farid, Mike Scully

Ir J Med Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosis.
Remedios Otero, Teresa Elias, Ana Montes-Worboys, Gloria Dawson, Remy Lampa, Mike Scully

Blood Coagul Fibrinolysis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM-15 disintegrin-like domain structure and function.
Dong Lu, Mike Scully, Vijay Kakkar, Xinjie Lu

Toxins (Basel)· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM proteins - therapeutic potential in cancer.
Xinjie Lu, Dong Lu, Mike Scully, Vijay Kakkar

Curr Cancer Drug Targets· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.
Xinjie Lu, Dong Lu, Mike Scully, Vijay Kakkar

Perspect Medicin Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma peptidome: A new approach for assessing thrombotic risk?
Mike F Scully

Thromb Haemost· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin binding characteristics of the disintegrin-like domain of ADAM-15.
Dong Lu, Kian Fan Chung, Min Xia, Xinjie Lu, Mike Scully

Thromb Haemost· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the single substitution of arginine within the RGD tripeptide motif of a modified neurotoxin dendroaspin on its activity of platelet aggregation and cell adhesion.
Xinjie Lu, Joanna Davies, Dong Lu, Min Xia, Beth Wattam, Mike Scully

Cell Commun Adhes· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, Ireland.
Mike Scully, Noreen Geoghegan, Paul Corcoran, Marika Tiernan, Eamon Keenan

J Subst Abuse Treat· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction.
Ferruccio De Lorenzo, Han Xiao, Zbigniew Kadziola, Mike Scully, Vijay Kakkar

Int J Cardiol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
Hans K Breddin, Zbigniew Kadziola, Mike Scully, Roumen Nakov, Frank Misselwitz

Thromb Haemost· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunction.
Ferruchio De Lorenzo, Han Xiao, Mike Scully, Zbigniew Kadziola, Vijay V Kakkar

Blood Coagul Fibrinolysis· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low molecular weight heparin (bemiparin sodium) and the coagulation profile of patients with heart failure.
Ferruccio De Lorenzo, Douglas Newberry, Mike Scully, Zibgniew Kadziola, Gloria Dawson

Am Heart J· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis.
Vijay V Kakkar, Debra A Hoppenstead, Jawed Fareed, Zbigniew Kadziola, Mike Scully

Blood· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis